Implantation or Injectable Dosage Form New Animal Drugs; Phenylbutazone Injection

摘要

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental abbreviated new animal drug application (ANADA) filed by Phoenix Scientific, Inc. The supplemental ANADA provides for use of phenylbutazone injection in dogs for relief of inflammatory conditions associated with the musculoskeletal system.